Methyl coumalate

We are Methyl coumalate CAS:6018-41-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  Methyl coumalate
CAS.NO:6018-41-3
Synonyms:
methyl 6-oxopyran-3-carboxylate

Molecular Formula:C7H6O4
Molecular Weight:154.12000

Physical and Chemical Properties:
Density: 1.326 g / cm3
Boiling point: 178-180 ° C60 mm Hg (lit.)
Melting point: 65-67 ° C (lit.)
Flash point: 178-180 ° C / 60mm
Refractive index: 1.513

Specification:
Appearance: White  powder
Purity:≥99%
Moisture Content: 0.25%
Impurity: 0.3%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Tazarotene  CAS:118292-40-3

Methyl coumalate


Related News: Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.3-Chlorobenzoyl chloride CAS:618-46-2 The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.515-83-3 Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.2,2'-Dithienyl Disulfide CAS:6911-51-9 Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.

Related Products
Product Name
N,O-Bis(trimethylsilyl)acetamide View Details
Pregn-​4-​en-​3-​one, 21-​hydroxy-​20-​methyl- View Details
2,4-Dichlorotoluene View Details
N-butyl pyridinium tetrafluoroborate manufacturer 1-Bromo-2-fluoro-3-nitrobenzene manufacturer 5,7-Dihydro-2-methylthieno[3,4-d]pyrimidine manufacturer 4,5-difluoro-1H-indole manufacturer N-(2-Pyridyl)bis(trifluoromethanesulfonimide) Cas:145100-50-1 manufacturer